Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Plasma Cell × talquetamab × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 27 Recurrence 4 Hematologic Neoplasms 2 Waldenstrom Macroglobulinemia 1 Neoplasm, Residual 1 Cytokine Release Syndrome 1

Interventions

fludarabine phosphate 4 fludarabine 4 Cyclophosphamide 4 Whole-Body Irradiation 3 Sirolimus 3 Lenalidomide 3 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Melphalan 2 venetoclax 1 sargramostim 1 montanide ISA 51 1 itacitinib 1 isatuximab 1 incomplete Freund's adjuvant 1 elotuzumab 1 Tacrolimus 1 High-Throughput Screening Assays 1 Hematopoietic Stem Cell Transplantation 1 Dexamethasone 1 Cyclosporine 1 Colony-Stimulating Factors 1 Budesonide 1 Bortezomib 1 Bendamustine Hydrochloride 1 Antilymphocyte Serum 1 Allopurinol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡